{"schema_version":"1.0","type":"article","title":"日本為什麼長不出全球級 Biotech？問題不在科學，而在產業生態","url":"https://drugnews.com.tw/articles/2026-07-09-japan-biotech-ecosystem-global-gap.html","markdown_url":"https://drugnews.com.tw/articles/2026-07-09-japan-biotech-ecosystem-global-gap.md","lang":"zh-Hant","date":"2026-07-09","publish_at":"2026-07-09T09:30:00+08:00","updated_at":"2026-07-09","category":"商業分析系列","topic":"商業分析系列","tags":["商業分析系列","免費文章","日本生技","Biotech ecosystem","startup ecosystem","創新藥","大藥廠","BD","臨床數據","CMC","資本市場","生技投資","製藥巨頭"],"summary":"日本不是缺少科學，也不是缺少大藥廠，而是缺少把大學技術、人才、資本、臨床與 BD 串成全球級 Biotech 的連續生態。","key_points":[],"facts":[],"sections":["01｜日本不是沒有創新底子，而是創新沒有長成新創公司","02｜日本大藥廠太強，反而壓縮了 Biotech 的成長空間","03｜人才問題更深：穩定職涯壓過創業流動","04｜資本水位不足，是日本 Biotech 最大的現實瓶頸","05｜改革已經開始，但生態不是政策一出就會長好","06｜這件事對台灣很重要：我們也不能只問誰有題材","07｜結語：Biotech 不是長不長得出來，而是生態有沒有讓它長大的耐心"],"references":[{"title":"Cabinet Secretariat, Government of Japan, [Startup Development Five-year Plan](), 2022.","source":"","date":"","url":"https://www.cas.go.jp/jp/seisaku/atarashii_sihonsyugi/pdf/sdfyplan2022en.pdf"},{"title":"Nature Index, [Japan country outputs]().","source":"","date":"","url":"https://www.nature.com/nature-index/country-outputs/Japan"},{"title":"Japan Agency for Medical Research and Development, [AMED official website]().","source":"","date":"","url":"https://www.amed.go.jp/en/"},{"title":"U.S. Food and Drug Administration, [Drug Trials Snapshot: Enhertu](), 2019.","source":"","date":"","url":"https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshot-enhertu"}],"images":[{"alt":"Facebook 原圖：日本為什麼長不出全球級 Biotech？問題不在科學，而在產業生態（圖 1）","url":"https://drugnews.com.tw/assets/articles/japan-biotech-ecosystem-global-gap/facebook-01.png"},{"alt":"Facebook 原圖：日本為什麼長不出全球級 Biotech？問題不在科學，而在產業生態（圖 2）","url":"https://drugnews.com.tw/assets/articles/japan-biotech-ecosystem-global-gap/facebook-02.png"},{"alt":"Facebook 原圖：日本為什麼長不出全球級 Biotech？問題不在科學，而在產業生態（圖 3）","url":"https://drugnews.com.tw/assets/articles/japan-biotech-ecosystem-global-gap/facebook-03.png"},{"alt":"Facebook 原圖：日本為什麼長不出全球級 Biotech？問題不在科學，而在產業生態（圖 4）","url":"https://drugnews.com.tw/assets/articles/japan-biotech-ecosystem-global-gap/facebook-04.png"}],"cover_image":"https://drugnews.com.tw/assets/articles/japan-biotech-ecosystem-global-gap/cover.png","publisher":{"name":"Drugnews｜藥時事","url":"https://drugnews.com.tw/","profile":"https://drugnews.com.tw/brand-profile.json"},"citation":"Drugnews｜藥時事（2026-07-09）。日本為什麼長不出全球級 Biotech？問題不在科學，而在產業生態。https://drugnews.com.tw/articles/2026-07-09-japan-biotech-ecosystem-global-gap.html","disclaimer":"本文僅供產業研究與知識分享，不構成投資、醫療、募資或個股建議。","translations":{"en":"2026-07-09-japan-biotech-ecosystem-global-gap-en.html"},"relationship":"independent_editorial","disclosure_url":"https://drugnews.com.tw/policy/"}